Venicia Considine
- Democratic
- Assembly Member
- District 18
Sponsor
(No further action taken.)
Vetoed by the Governor.
Senate Amendment No. 644 concurred in. To enrollment. Enrolled and delivered to Governor.
In Assembly.
Read third time. Passed, as amended. Title approved, as amended. Preamble adopted, as amended. (Yeas: 13, Nays: 7, Excused: 1.) To Assembly.
Taken from General File. Placed on General File for next legislative day.
From printer. To re-engrossment. Re-engrossed. Second reprint. Taken from General File. Placed on General File for next legislative day.
From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 644.) To printer.
In Senate. Read first time. Referred to Committee on Commerce and Labor. To committee.
From printer. To engrossment. Engrossed. First reprint. Read third time. Passed, as amended. Title approved. Preamble adopted. (Yeas: 27, Nays: 15.) To Senate.
From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 439.) To printer.
From printer. To committee.
Read first time. Referred to Committee on Commerce and Labor. To printer.
| Bill Text Versions | Format |
|---|---|
| As Introduced | |
| Amendment 439 | |
| Reprint 1 | |
| Amendment 644 | |
| Reprint 2 | |
| As Enrolled |
| Document | Format |
|---|---|
| AB250 Testimony in Neutral, submitted by D. Gattine, Sr. Policy Consultant, on behalf of the Nat'l Academny for State Health Policy (NASHP) | |
| AB250 Testimony in Neutral, submitted by T. McCoy, JD, Exec. Director, State Govt. Affairs, Nevada Chronic Care Collaborative | |
| AB250 Testimony in Opposition, submitted by R. Hamson, Exec. Director Region Teams, on behalf of Epilepsy Foundation Nevada | |
| AB250 Letter in Opposition, submitted by R. Aryel, M.D., M.B.A. | |
| AB250 Testimony in Opposition, submitted by S. Desselle, RPh, PhD, FAPhA, President of Applied Pharmacy Solutions | |
| AB250 Testimony in Opposition, submitted by L. Lindahl, Vice President, on behalf of Healthcare Distribution Alliance (HDA) | |
| AB250 Testimony in Opposition, submitted by J. Laub, President, Nevada Biotechnology & Health Science Consortium | |
| AB250 Letter of Opposition, submitted by P. Kelly, President & CEO, Nevada Hospital Assn. | |
| AB250 Testimony in Opposition, submitted by A. Barber, MD, FACS, President, NV Oncology Society, and L. Pierce, MD, FASTRO, FASCO, Chair of the Board, Assn. for Clinical Oncology | |
| AB250 Testimony in Opposition, submitted by D. Thompson on behalf of Pharmaceutical Industry Labor-Management Assn. (PILMA) | |
| AB250 Testimony in Opposition, submitted by R. Finseth, President, Carrara Nevada, on behalf of PhRMA | |
| AB250 Testimony in Opposition, submitted by J. Lau, Vice President, Ferrari Reeder, on behalf of Biotechnology Innovation Organization (Bio) | |
| AB250 Letter of Support, submitted by C. McMullen, President, on behalf of the Senior Coalition of Washoe County | |
| AB250 Testimony in Support, submitted by S. Gleich, Chief Executive Director, on behalf of Nevada Diabetes Assn. | |
| AB250 Testimony in Support, submitted by K. Wulfkuhle, State External Affairs Manager, for United States of CARE | |
| AB250 Testimony in Support, submitted by M. Fitzgerald on behalf of New Day Nevada | |
| AB250 Testimony in Support, submitted by J. Partida Corona, MD | |
| AB250 Testimony in Support, submitted by D. Lide | |
| AB250 Letter of Support, submitted by M. Guerrero | |
| AB 250 Letter of Support, submitted by S. Horner | |
| AB250 Proposed Amendment, submitted by Assemblywoman Considine | |
| AB250 Second Proposed Amendment, submitted by Assemblywoman Considine | |
| AB250 Work Session Document | |
| AB250_RX Drug Cost Stability Act_Assemblywoman Venicia Considine | |
| AB250_Conceptual Amendment_Assemblywoman Venicia Considine | |
| AB250_Letters in Opposition | |
| AB250_Opposition Letter_Brian Warren_Biotechology Innovation Organization | |
| AB250_Opposition Letter_Kaylynn Bowman PharmD MS Med_Nevada Pharmacy Alliance | |
| AB250_Opposition Letter_PhRMA | |
| AB250_Opposition Letter_Various groups | |
| AB250_Oppostion Letter_Alisa Reinhardt_Bayer | |
| AB250_Elizabeth Yanez support letter | |
| AB250 (R1)_Work Session Document_Cesar Melgarejo_Committee Policy Analyst |
Data on Open States is updated periodically throughout the day from the official website of the Nevada Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.